Company · founded 1961
Advanced Bioscience Laboratories (United States)
Rockville, United States · ablinc.com
- Citations, last 5 years
- 130
- Works, last 5 years
- 11
- h-index
- 96
- Scientists listed
- 4
- Grants since 2016
- 173
Grants received
2019–2020 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC)
Pal Ranajit · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2019–2025 · contract · N01
cGMP Manufacturing of Glycopeptide Immunogen Nanoparticle Vaccine
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2019–2020 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2019–2020 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
Task X7: Malaria Vaccines Stability Study
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V06: Process development and manufacture of cGMP compliant parvovirus B19 vaccine drug product for use in Phase I/II clinical trials
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V30: GMP Manufacturing of WNV Vaccine
Wang Hong · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2026 · contract · N01
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2023 · contract · N01
NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines
Thomas Vancott · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
OVINE MODEL AND VAGINAL MICROBIOME SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT.
Glenn Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2023 · contract · N01
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V27: Stability Testing of CpG
Andreas Neubert · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2023 · contract · N01
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
John Mascola · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2020 · contract · N01
Evaluation of the Immunogenicity and Efficacy of a MVA-HIV Prime, gp145 HIV protein/ALFA-adjuvanted Boost Vaccine Regimen with SHIV-CH505 Challenge in Male Rhesus Macaques
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2021 · contract · N01
PRECLINICAL GAP-FILLING SERVICES: STUDIES TO ASSESS INTERACTIONS BETWEEN DAPIVIRINE AND VAGINALLY-APPLIED, OVER-THE-COUNTER PRODUCTS
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2021 · contract · N01
Preclinical Gap-Filling Services: Studies to Assess Interactions Between Dapivirine and Vaginally-Applied, Over-The-Counter Products
Maria Grazia Ferrari · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2020 · contract · N01
EVALUATION OF THE IMMUNOGENICITY AND EFFICACY OF HIV-1 CLADE C OLIGOMERIC ENVELOPE PROTEIN DELIVERED WITH ADVAX DELTA INULIN ADJUVANT BY INTRAMUSCULAR AND INTRAPULMONARY ROUTES
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2022 · contract · N01
Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2026 · contract · N01
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
NONHUMAN PRIMATE PURCHASE AND HOLDING
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2018–2028 · contract · N01
Vaccine Manufacturing and Characterization Services
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
SUPPORT FOR REGULATORY EXPERTISE IN THE DEVELOPMENT OF LIVE BIOTHERAPEUTIC AGENTS
Glen Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
OVINE MODEL AND VAGINAL MICROBIOME SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT.
Glenn Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2021 · contract · N01
Task X20: Manufacture and Characterization Services for Vaccines and Other Biologics for Infectious Diseases
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDES AND BIOMEDICAL PREVENTION
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
NIAID Preclinical Development Support: Essential Core Activities
Timothy R Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
cGMP Manufacturing of Monoclonal Antibodies (mAbs) Against HIV
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2020 · contract · N01
NIAID Preclinical Development Support
Fred Mack · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2022 · contract · N01
Production of Adjuvants
Fred Mack · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2019 · contract · N01
Evaluation of Immune Responses to a Trimerically Stabilized gp120 Immunogen
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2023 · contract · N01
Production of Aluminum Based Adjuvants
Fred Mack · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2026 · contract · N01
Fill-Finish, Release, and Stability Testing of HIV-1 gp120 Proteins
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
Evaluation of the Immunogenicity and Efficacy of a DNA Prime/Protein Boost Vaccine
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2021 · contract · N01
Evaluation of the Immunogenicity and Efficacy of a DNA Prime/Protein Boost Vaccine
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
NIAID Preclinical Development Support: Essential Core Activities
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
TASK X21: ADMINISTRATIVE - MANUFACTURING AND CHARACTERIZATION SERVICES FOR VACCINES AND OTHER BIOLOGICS
Ziv Sandalon · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
Development of HIV Non-Vaccine Biomedical Prevention Products: Product Attributes, Positioning, and Messaging to Drive Adoption and Use of New Personal Use Products
Glen Swartz · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2022 · contract · N01
Fill-Finish, Release, and Stability Testing of HIV-1 gp120 Proteins
Fred Mack · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2024 · contract · N01
NIAID Preclinical Development Support: Essential Core Activities
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
Product Development Plan for Cholera Product
Sandalon Ziv · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health